Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities

Wang T., Askan G., Ozcan K., Rana S., Zehir A., Bhanot U. K., ...Daha Fazla

Archives of Pathology and Laboratory Medicine, cilt.147, sa.12, ss.1390-1401, 2023 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 147 Sayı: 12
  • Basım Tarihi: 2023
  • Doi Numarası: 10.5858/arpa.2022-0343-oa
  • Dergi Adı: Archives of Pathology and Laboratory Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Public Affairs Index
  • Sayfa Sayıları: ss.1390-1401
  • Marmara Üniversitesi Adresli: Evet

Özet

Context.—Tumoral (grossly visible) intraductal neoplasms of the bile ducts are still being characterized. Objective.—To investigate their morphologic, immunohistochemical, and molecular features. Design.—Forty-one cases were classified as gastric-, intestinal-, pancreatobiliary-type intraductal papillary neoplasm (IPN), intraductal oncocytic papillary neoplasm (IOPN), or intraductal tubulopapillary neoplasm (ITPN) on the basis of histology. All neoplasms were subjected to targeted next-generation sequencing. Results.—The mean age at diagnosis was 69 years (42–81 years); male to female ratio was 1.3. Most neoplasms (n ¼ 23, 56%) were extrahepatic/large (mean size, 4.6 cm). The majority (n ¼ 32, 78%) contained high-grade dysplasia, and 68% (n ¼ 28) revealed invasion. All gastric-type IPNs (n ¼ 9) and most ITPNs/IOPNs showed consistent colabeling for CK7/MUC6, which was less common among others (P ¼ .004). Intestinal-type IPNs (n ¼ 5) showed higher rates of CK20 expression than others (P, .001). Overall, the most commonly mutated genes included TP53 and APC, while copy number variants affected ELF3 and CDKN2A/B. All gastric-type IPNs contained an alteration affecting the Wnt signaling pathway; 7 of 9 (78%) showed aberrations in the MAPK pathway. Mutations in APC and KRAS were common in gastric-type IPNs as compared with others (P ¼ .01 for both). SMAD4 was more frequently mutated in intestinal-type IPNs (P ¼ .02). Pancreatobiliary-type IPNs (n ¼ 14) exhibited frequent alterations in tumor suppressor genes including TP53, CDKN2A/B, and ARID2 (P ¼ .04, P ¼ .01 and P ¼ .002, respectively). Of 6 IOPNs analyzed, 3 (50%) revealed ATP1B1-PRKACB fusion. ITPNs (n ¼ 6) showed relatively few recurrent genetic aberrations. Follow-up information was available for 38 patients (median, 58.5 months). The ratio of disease-related deaths was higher for the cases with invasion (56% versus 10%). Conclusions.—Tumoral intraductal neoplasms of the bile ducts, similar to their counterparts in the pancreas, are morphologically and genetically heterogeneous. (Arch Pathol Lab Med. 2023;147:1390–1401; doi: 10.5858/arpa.2022-0343-OA).